Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 144 (3), 282-5

Striatal Dopamine Transporter Density in Major Depression


Striatal Dopamine Transporter Density in Major Depression

T Laasonen-Balk et al. Psychopharmacology (Berl).


Rationale: There are no previous data available regarding [123I]beta-CIT binding to the dopamine transporter sites in the basal ganglia in depressed patients.

Objective: The present study tested the hypothesis that the brain DAT density in depressed patients is lower than that in matched healthy controls.

Methods: Fifteen drug-naive outpatients with major depression and 18 healthy controls were investigated using single photon emission computerized tomography (SPECT) with a high-affinity dopamine transporter specific radioligand. 123I-labeled beta-CIT (2beta-carbomethoxy-3beta-(4-iodophenyl-tropane).

Results: We found a significantly higher [123I]beta-CIT uptake in both sides of the basal ganglia in patients with major depression than in the controls (Mann-Whitney U-test, P = 0.002 on the right and P = 0.003 on the left).

Conclusions: The radioligand uptake reflecting the DAT density was significantly higher among the patients than in the controls. This finding is unexpected, since it is generally believed that monoaminergic neurotransmission is lower in depression, and therefore it could be assumed that a reduction in dopamine transmission would lead to secondary down-regulation of DAT density. However, it is possible that up-regulation of the DAT may be the primary alteration, which leads to lower intrasynaptic dopamine concentration and to lower dopamine neural transmission.

Similar articles

See all similar articles

Cited by 27 PubMed Central articles

See all "Cited by" articles

MeSH terms


LinkOut - more resources